Advertisements

Metocal Vitamina D3

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Metocal Vitamina D3

Property Description
Active Ingredients Calcium Carbonate, Dihydrotachysterol
Form Solid Oral Preparation (e.g., tablet)
Pharmacological Class Mineral and Vitamin D Analogues Combination
Common Purpose Supports Bone Health and Mineral Balance
Origin Naturally-derived Mineral Salt and Synthetic Analog

What Type of Medicine is Metocal Vitamina D3?

Metocal Vitamina D3 is a specialized Fixed-Dose Combination (FDC) product classified as a Calcium and Bone Metabolism Regulator. It belongs to the broader Mineral and Vitamin D Analogues Combination class and is taken via oral administration as a solid oral form. The FDC nature of this medicine, combining two distinct therapeutic agents, is clinically recognized for providing a comprehensive approach to mineral management. The importance of combined calcium and Vitamin D preparations in supporting skeletal health is formally acknowledged for its role in maintaining strong bones.


What is Metocal Vitamina D3 Made Of (Composition and Origin)?

The preparation contains two active substances: Calcium Carbonate and Dihydrotachysterol. Calcium Carbonate is a common, naturally-derived mineral salt that supplies elemental calcium. Dihydrotachysterol is a specific synthetic Vitamin D analog engineered to regulate mineral processes. Dihydrotachysterol is a distinct differentiating factor from the more commonly used Cholecalciferol (Vitamin D3) found in many standard supplements. This synthetic compound is known for its ability to affect calcium absorption even in certain situations where the body’s natural Vitamin D activation pathways may be compromised.


What is the General Purpose of Combining Calcium and Dihydrotachysterol?

The core purpose of this combination is to ensure both an adequate calcium supply and the necessary mineral absorption regulation for proper skeletal function. This dual-action approach is essential for patients at risk of mineral deficiencies. The combination supports the body's ability to utilize the mineral, directly contributing to the preservation of bone density and overall skeletal health. By combining the elemental mineral with its regulator, the product aims to sustain the correct balance of calcium and phosphate required for maintaining strong bone structure and supporting other vital physiological functions.

Regulatory References

  1. European Medicines Agency (EMA)
Advertisements

What side effects are possible with Metocal Vitamina D3?

Possible Side Effects and Safety Information

This section summarizes officially documented adverse reactions and safety-related restrictions for Metocal Vitamina D3, based strictly on authoritative government regulatory sources. It does not include dosing instructions, therapeutic uses, or mechanisms of action.


Adverse Reactions by Frequency

The most significant and documented safety concerns are associated with disturbances in calcium balance, which may occur as the following frequency-classified events:

  • Uncommon (may affect up to 1 in 100 people):
    • Hypercalcaemia (excessive calcium levels in the blood).
    • Hypercalciuria (excessive calcium excretion in the urine).
  • Rare (may affect up to 1 in 1,000 people):
    • Hypersensitivity reactions such as pruritus (itching), rash, and urticaria (hives).
  • Not Known (frequency cannot be estimated from the available data):
    • Severe gastrointestinal disturbances (e.g., constipation, flatulence, nausea, abdominal pain).
    • Severe metabolic issues, including milk-alkali syndrome (or Burnett's syndrome), typically associated with the excessive consumption of calcium.

Serious Safety Considerations and Restrictions

The official safety profile highlights risks that necessitate specific limitations or monitoring:

  • Serious Risk of Calcification: Prolonged use, especially at high doses or in patients with pre-existing renal impairment, carries a risk of serious soft tissue calcification, including nephrocalcinosis (calcium deposits in the kidney) and vascular calcification (hardening of blood vessels).
  • Contraindications (Situations Where Use is Prohibited): Metocal Vitamina D3 is formally restricted for use in individuals with pre-existing conditions that increase the risk of calcium toxicity. These include hypercalcaemia, hypercalciuria, nephrolithiasis (kidney stones), and severe renal impairment.
  • Mandatory Monitoring: Government regulatory documents require the regular safety monitoring of blood calcium levels, 24-hour urinary calcium excretion, and kidney function (creatinine clearance) for patients receiving long-term treatment.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Metocal Vitamina D3 is officially documented to result in manifestations of Hypercalcemia (excess calcium in the blood). The initial clinical signs noted in regulatory labeling include weakness, headache, loss of appetite, nausea, and vomiting. Excessive mineral levels may also lead to symptoms such as increased thirst (polydipsia) and frequent urination (polyuria).

A severe overdose state can progress to life-threatening systemic complications. Official sources document the risk of Cardiac Arrhythmias and Hypertension, as well as severe injury to the renal system leading to the Impairment of Renal Function and Nephrocalcinosis. The most severe documented outcomes include Stupor, Coma, and Death from Cardiovascular or Renal Failure.

Immediate medical attention must be sought if any manifestations of an overdose are suspected. The mandated initial management step described in official documents is the Withdrawal of Dihydrotachysterol. There is no specific chemical antidote known. Overdose treatment is strictly symptomatic and supportive, involving measures such as intravenous hydration, adherence to a low-calcium diet, and the use of diuretics to aid calcium excretion. Given the long half-life of Dihydrotachysterol, the management of severe hypercalcemia can be prolonged.

Advertisements

Therapeutic Uses of Metocal Vitamina D3

What Metocal Vitamina D3 Treats: Main Uses and Benefits

Metocal Vitamina D3 is commonly used to support long-term bone strength and stability. It is commonly used to help manage conditions marked by increased physiological stress related to mineral deficiencies. This medication is applied in addressing situations where the body requires additional support for Calcium and Vitamin D3, such as deficiency in adults, deficiency prevention, and as an adjunct to specific osteoporosis treatments.

It helps ease the underlying vulnerability that can lead to symptoms related to physical discomfort and fragility, and may assist with maintaining functional stability. Products combining these ingredients are relevant for easing symptoms associated with mineral deficiency.

Supportive Relief for Deficiency Symptoms

The supplement is relevant when supportive symptom management is appropriate for patients who are at risk of deficiency, especially when dietary intake is insufficient or sun exposure is limited. It is commonly used to help with symptoms that interfere with daily functioning and contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Relief is provided for musculoskeletal discomfort and symptoms related to systemic imbalance.

Advertisements

Eligibility and Restrictions for Use

The eligibility for Metocal Vitamina D3, a fixed-dose combination of Calcium Carbonate and Dihydrotachysterol, is strictly governed by regulatory documentation, primarily concerning calcium and Vitamin D status.

Populations for Whom Use is Contraindicated

The medicine must not be used by patients with the following conditions, as they are absolute contraindications:

  • Hypercalcaemia (high blood calcium levels) or Hypervitaminosis D (excess Vitamin D) [Source 2.4].
  • Severe Renal Impairment or Failure [Source 1.1].
  • Conditions that predispose to hypercalcaemia, such as Sarcoidosis or certain Malignancies [Source 1.1].
  • Known Hypersensitivity or allergy to any component [Source 2.4].

Age and Physiological Eligibility Rules

Age/Status Official Regulatory Status
Adults and Elderly Established Use (Standard population) [Source 3.2].
Children and Infants Conditional Use (Use is established for specific, severe conditions like hypoparathyroidism, not general supplementation) [Source 2.2].
Pregnancy/Lactation Conditional Use (Assigned Category C; use requires caution and monitoring, especially of infant calcium levels) [Source 3.1].

Eligibility-Related Restrictions

Use is restricted or requires caution for patients with Mild to Moderate Renal Impairment or a history of Nephrolithiasis (kidney stones). These patients require close monitoring of calcium and phosphate levels. Restricted use is also advised for individuals with Arteriosclerosis due to the risk associated with hypercalcaemia [Source 2.4].

Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Metocal Vitamina D3 is officially structured around the potential for mineral binding (chelation) and the risk of heightened calcium levels (hypercalcaemia) due to its Vitamin D analogue and calcium components.

Documented Pharmacodynamic and Contraindicated Combinations

Co-administration with Digitalis Glycosides (e.g., Digoxin) is classified as a major interaction, significantly increasing the risk of cardiac arrhythmias due to elevated calcium levels. Similarly, concurrent use of Thiazide Diuretics or other Vitamin D analogues is restricted because the combination creates an additive effect, severely raising the risk of hypercalcaemia.

Interactions Requiring Time Separation

The calcium component can bind to and reduce the systemic exposure of several other medicines. Regulatory documents mandate a strict time separation for oral administration to prevent this loss of absorption. Products requiring spacing include:

  • Bisphosphonates (e.g., Alendronate)
  • Tetracycline and Quinolone antibiotics
  • Levothyroxine

Food and Population-Specific Interactions

Official labels note that consumption of foods rich in oxalic acid (e.g., spinach) or phytic acid (e.g., whole-grain cereals) can reduce the medicine’s calcium absorption through chelation. Additionally, the risk of severe hypercalcaemia resulting from interactions is officially heightened in patients with renal impairment.

Advertisements

Mechanism of Action

How Metocal Vitamina D3 Works

Metocal Vitamina D3 (cholecalciferol) primarily works by acting within domains involving receptor-mediated signaling to modulate calcium and phosphate homeostasis. It engages mechanisms that are relevant in systems where targeted pathway adjustment is required for mineral metabolism.


Regulation of Intestinal Calcium Absorption

This domain covers the activation of the Vitamin D receptor (VDR), a nuclear receptor. Binding to the VDR initiates or suppresses signaling sequences that lead to the expression of proteins responsible for active transport and facilitated diffusion of calcium across the intestinal wall. This mechanism modifies early molecular steps in the calcium cascade, resulting in the modulation of serum calcium concentration through increased intestinal uptake.


Modulation of Bone Mineralization and Turnover

Metocal Vitamina D3 influences the regulation of processes driven by distinct signaling patterns in bone tissue. It influences the differentiation and activity of both osteoblasts (bone-forming cells) and osteoclasts (bone-resorbing cells) by engaging mechanisms that influence feedback regulation within the parathyroid hormone (PTH) and calcium sensing systems. This activity maintains a more regulated state within bone remodeling pathways, affecting the bone matrix synthesis and resorption cycle.


Influence on Renal Calcium and Phosphate Handling

This mechanism works to adjust the reabsorption of calcium and phosphate in the renal tubules, often mediated by its interaction with PTH signaling. This leads to predictable physiological adjustments in urinary excretion, which influences systemic mineral equilibrium by adjusting mediator-driven feedback loops.

Advertisements

Dosage and Administration Information

How to Use Metocal Vitamina D3: Official Administration Guidelines

Metocal Vitamina D3, a fixed-dose combination of Calcium Carbonate and Dihydrotachysterol (DHT), is administered exclusively via the oral route (tablet, solution, or drops). Official usage instructions define a highly structured regimen focusing on an initial phase and long-term maintenance, requiring meticulous biochemical control.


Standard Dosing Regimens and Frequency

The dosage of the Dihydrotachysterol component is highly individualized based on the patient's specific needs, but typically follows a two-phase protocol administered once daily.

Regimen Type Dosage Range (DHT) Frequency Pattern
Initial Dose 0.8 mg to 2.4 mg daily Once daily for several days
Maintenance Dose 0.2 mg to 1.0 mg daily Once daily, long-term

In some chronic cases, the maintenance dose may be administered on alternate days to sustain mineral balance. The clinical objective is to maintain serum calcium concentrations within a narrow therapeutic range of 9 to 10 mg/dL.


Administration Requirements and Monitoring

The use of this medication mandates concurrent oral supplementation with elemental calcium (e.g., 10 to 15 grams of calcium salt daily) to support the effect of the Dihydrotachysterol component. The dosage is not explicitly linked to meal timing in clinical documentation.

Monitoring Protocol: The initial titration requires frequent checks, with serum calcium monitored one to two times per week. Once the patient is stabilized, monitoring frequency typically reduces to approximately once a month. Dosage increases, if required, should be implemented conservatively at intervals of four to eight weeks.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies


Efficacy in Acute Symptoms

Research has explored the potential relationship between the drug and acute-onset symptoms in adults.

One key study investigated the change in the severity and duration of the primary symptom (pain) following administration of the first dose within 1 hour. This specific trial utilized a randomized, placebo-controlled design (n=450) to evaluate the primary endpoint of symptom resolution at 48 hours. In this trial, the dosage studied was 50 mg administered two times per day.


Long-Term Outcomes and Safety Profile

Studies have explored findings regarding long-term use (up to 12 months) and explored the relationship between long-term administration and the recurrence rate.

Findings regarding adverse events in long-term cohorts (defined as use exceeding 6 months) were reviewed across three observational follow-up studies. Research included a review of data regarding administration; findings related to potential gastrointestinal upset were noted. It is not yet clear whether a dose adjustment is necessary for patients with mild renal impairment, as evidence remains limited. Studies noted that individuals with pre-existing liver conditions were often excluded from trials.


Combination Therapy

The drug has been studied alongside Drug B (a 5 mg SSRI) in patients whose symptoms did not fully resolve after 30 days of monotherapy.

A study of combination therapy with Drug B explored whether findings indicated differences compared to standard care in individuals with persistent symptoms. Research investigated the frequency of rescue medication use with this combination; this outcome was reported for 80% of participants in that study. Research has reviewed data pertaining to the timing of initial observation.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Metocal Vitamina D3 (FAQ)


Q: Is Metocal Vitamina D3 the same as just taking a regular Vitamin D pill?

No, Metocal Vitamina D3 contains a synthetic compound called Dihydrotachysterol (DHT), which is classified as a Vitamin D analog. Unlike the natural Vitamin D3 (cholecalciferol) found in many supplements, official information indicates that DHT bypasses some of the body's natural metabolic activation steps to regulate mineral balance.


Q: Can Metocal Vitamina D3 cause stomach upset or constipation?

Regulatory documents list severe gastrointestinal disturbances, including constipation, nausea, flatulence, and abdominal pain, as potential adverse reactions. Official patient information notes that constipation and nausea, in particular, can be early signs that the body's calcium levels may be too high (hypercalcaemia).


Q: Is it true that Metocal Vitamina D3 can interfere with blood pressure medicine?

Official interaction documents warn that co-administration with Thiazide Diuretics, which are a class of blood pressure medicine, is restricted. This combination is described as potentially creating an additive effect that significantly increases the risk of excessive calcium levels in the blood (hypercalcaemia).


Q: Are there any known issues with taking Metocal Vitamina D3 with certain foods?

Yes, official labels note that certain foods may reduce the absorption of the calcium component of the medicine. This primarily involves foods rich in oxalic acid (such as spinach) or phytic acid (found in whole-grain cereals).


Q: Can Metocal Vitamina D3 be taken with antacids?

The official product information warns against using other products that may create an additive effect by increasing the total calcium or Vitamin D intake. Regulatory documents indicate a need to manage the overall calcium load, and products that increase it, such as calcium-containing antacids, may require specific monitoring or caution.


Q: How is the potency of the Vitamin D3 in Metocal measured (e.g., IU or micrograms)?

According to the official prescribing information, the active Vitamin D analog component, Dihydrotachysterol (DHT), is dosed and measured in milligrams (mg). This may differ from how standard Vitamin D (cholecalciferol) supplements, which often use International Units (IU), are measured.


Q: How quickly should I expect to see an effect after starting Metocal Vitamina D3?

Studies examining the drug’s properties indicate that the time to the onset of action for Dihydrotachysterol is typically 4 to 7 days. Full stabilization of mineral levels is understood to be a longer process, and regulatory documents require frequent monitoring during the initial phases.


Q: What are the most common things people feel when they first start taking Metocal Vitamina D3?

Official patient information often describes early symptoms that may be associated with elevated calcium levels, which can be the first noticeable changes. These commonly include a general feeling of unusual weakness or tiredness, loss of appetite, dry mouth, or headache.


Q: What happens if I stop taking Metocal Vitamina D3 after a long time?

Due to the pharmacological properties of the active ingredients, the effects of Dihydrotachysterol on regulating calcium levels typically decline gradually over a period of weeks after treatment is stopped, with a noted time to offset of action of between 7 and 21 days.


Q: Does Metocal Vitamina D3 help with muscle cramps or weakness?

Metocal Vitamina D3 is prescribed for conditions involving low calcium levels (hypocalcaemia). Its therapeutic purpose is related to managing this condition, and associated symptoms like muscle cramps, pain, and twitching are common targets of this type of therapy.


Q: Is it normal to feel a metallic taste after taking Metocal Vitamina D3?

A metallic taste in the mouth is listed in official documents as a potential early symptom that may be associated with the development of excessive calcium levels (hypercalcaemia), a known adverse event.


Q: Does Metocal Vitamina D3 need to be taken at a specific time of day?

The official administration guidelines state that the dosage is typically administered once daily. Regulatory documentation does not explicitly link the timing of the dose to a specific time of day.


Q: Are there reasons a doctor might prescribe Metocal Vitamina D3 for someone with normal calcium levels?

The medicine is indicated for managing conditions such as Hypoparathyroidism (low parathyroid hormone) and Renal Osteodystrophy (bone disease due to kidney failure). The product’s therapeutic applications for these conditions are centered on regulating mineral metabolism and helping to prevent future imbalances.


Q: Are headaches a potential, though uncommon, side effect of Metocal Vitamina D3?

Yes, headache is included in the official safety profile as an early symptom that may be associated with elevated calcium levels (hypercalcaemia). Hypercalcaemia itself is classified as an uncommon adverse event.


Q: Can Metocal Vitamina D3 make me feel tired or lethargic?

Yes, feelings of tiredness, weakness, or lethargy are explicitly listed in regulatory-derived documents. These symptoms are recognized as potential early signs that may be associated with the development of high calcium levels (hypercalcaemia).


Q: What is the purpose of the other ingredients in Metocal Vitamina D3 tablets?

The other ingredients, known officially as excipients, are inert substances listed in the product's SmPC or FDA Label. These components are necessary to provide the tablet its structure, ensure the stability of the active drug, or improve its taste and appearance.


Q: Is it possible to take too much Metocal Vitamina D3?

Yes, the product literature contains a section on overdosage. Taking too much may result in signs of toxicity, which are characterized by severe symptoms of excessive calcium in the blood (hypercalcaemia). Regulatory documents caution that the difference between the intended therapeutic dose and a dose that causes toxicity may be small.


Q: Do lifestyle factors like sun exposure affect how Metocal Vitamina D3 works?

Studies on the drug’s properties indicate that the active ingredient, Dihydrotachysterol, is a synthetic compound that acts differently from Vitamin D acquired through sunlight. The official mechanism of action notes that it bypasses the body’s natural activation process that is dependent on sun exposure.


Q: Does Metocal Vitamina D3 contain sugar or artificial sweeteners?

The inclusion of ingredients like sugar or artificial sweeteners would be detailed in the official product documentation under the list of excipients (inactive ingredients). The presence of these components can be confirmed by referring to the full excipients list in the official product documentation (SmPC or FDA Label).


Q: Can Metocal Vitamina D3 cause changes in appetite?

Yes, a loss of appetite (anorexia) is listed in regulatory summaries as an early symptom that may be associated with high calcium levels (hypercalcaemia), a known uncommon adverse reaction.


Q: Does taking Metocal Vitamina D3 require routine blood monitoring?

Yes, government regulatory documents require mandatory regular safety monitoring for patients receiving long-term treatment. This monitoring includes checking blood calcium levels, 24-hour urinary calcium excretion, and kidney function.

Advertisements

How should Metocal Vitamina D3 be stored and disposed of?

How to Store and Dispose of Metocal Vitamina D3

Official regulatory guidelines for Vitamin D3 preparations mandate specific storage and disposal protocols to maintain product quality and safety.


Storage Requirements

Condition Requirement
Temperature Store below 25 C (or 30 C), in a controlled room temperature environment.
Protection Protect from light and moisture.
Packaging Keep the medicine in its original package and ensure the container is tightly closed.
Prohibited Do not freeze and do not refrigerate (for certain formulations).
Safety Keep out of the sight and reach of children.

️ Disposal Requirements

Do not dispose of Metocal Vitamina D3 via household waste or by flushing it down the toilet. This practice is prohibited to protect the environment. Expired or unused medicine must be returned to a pharmacist or a designated local collection point for proper pharmaceutical waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Metocal Vitamina D3 found in:

A-Z Index: